Purkinje cell vulnerability and autism: A possible etiological connection

Brain and Development

Volumn 25, Issue 6, 2003, Pages 377-382

  Kern, Janet Kinnear ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Autism; Etiology; Gliosis; Heterogeneity; Insult; Onset; Purkinje cell; Vulnerability

Indexed keywords

AUTISM; BRAIN DEVELOPMENT; BRAIN GROWTH; BRAIN INJURY; CELL LOSS; DETERIORATION; GLIOSIS; HUMAN; MEDICAL LITERATURE; MEDICAL RESEARCH; NERVE CELL; NERVE CELL NECROSIS; NONHUMAN; ONSET AGE; PREGNANCY; PRENATAL CARE; PURKINJE CELL; REVIEW;

EID: 0042626390     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0387-7604(03)00056-1     Document Type: Review

References (89)

1. Bryson S.E., Clark B.S., Smith I.M. First report of a Canadian epidemiological study of autistic syndromes. J Child Psychol Psychiatry. 29:1988;433-446.
2. Sugiyama T., Abe T. The prevalence of autism in Nagoya, Japan: a total population study. J Autism Dev Disord. 19:1989;87-96.
3. Baird, G, Charman, T, Baron-Cohen, S, Cox, A, Swettenham, J, Wheelwright, S, et al., Screening a large population of 18 months olds with the CHAT, Paper presented at the Proceedings of the Society for Research on Child Development, Albuquerque, NM, (1999).
4. California Department of Developmental Services, Changes in the population of persons with autism and pervasive developmental disorders in California's Developmental Services System:1987 through 1998, (1998), http://www.autism.com/ari/dds/dds.html.
5. Chakrabarti S., Fombonne E. Pervasive developmental disorders in preschoolchildren. JAMA. 285:(24):2001;3093-3099.
6. Diagnostic and statistical manual of mental disorders. 1994;Author, Washington, DC.
7. Filipek P.A., Accardo P.J., Baranek G.T., Cook E.H. Jr, Dawson G., Gordon B., et al. The screening and diagnosis of autistic spectrum disorders. J Autism Dev Disord. 29:1999;439-484.
8. Frith U. Autism: explaining the enigma. 1997;Blackwell Publishers Ltd, Oxford.
9. Cohen D., Volkmar F. Autism and pervasive developmental disorders. 2nd Edition:1997;John Wiley & Sons, Inc, New York.
10. Dunn M.E., Burbine T., Bowers C.A., Tantleff-Dunn S. Moderators of stress in parents of children with autism. Community Ment Health J. 37:(1):2001;39-52.
11. Courchesne E. Neuroanatomic imaging in autism. Pediatrics. 87:(5pt2):1991;781-790.
12. Courchesne E. New evidence of cerebellar and brain stem hypoplasia in autistic infants, children, and adolescents: the MR imaging study by Hashimoto and colleagues. J Autism Dev Disord. 25:(1):1995;19-22.
13. Kemper T.L., Bauman M.L. The contribution of neuropathologic studies to the understanding of autism. Neurol Clin. 11:(1):1993;175-187.
14. Ritvo E.R., Freeman B.J., Scheibel A.B., Duong T., Robinson H., Guthrie D., et al. Lower Purkinje cell counts in the cerebella of four autistic subjects: initial findings of the UCLA-NSAC autopsy research reports. Am J Psychiatry. 143:1986;862-866.
15. Bailey A., Luthert P., Dean A., Harding B., Janota I., Montgomery M., et al. A clinicopathological study of autism. Brain. 121 (Pt5):1998;889-905.
16. Williams R.S., Hauser S.L., Purpura D.P., DeLong G.R., Swisher C.N. Autism and mental retardation: neuropathologic studies performed in four retarded persons with autistic behavior. Arch Neurol. 37:1980;749-753.
17. Warren R.P., Singh V.K., Cole P., Odell J.D., Pingree C.B., Warren W.L., et al. Possible association of the extended MHC haplotype B44-SC30-DR4 with autism. Immunogenetics. 36:(4):1992;203-207.
18. Warren R.P., Yonk L.J., Burger R.A., Cole P., Odell J.D., Warren W.L., et al. Deficiency of suppressor-inducer (CD4+CD45RA+) T cells in autism. Immunol Invest. 19:(3):1990;245-251.
19. Warren R.P., Yonk J., Burger R.W., Odell D., Warren W.L. DR-positive T cells in autism: association with decreased plasma levels of the complement C4B protein. Neuropsychobiology. 31:(2):1995;53-57.
20. Horvath K., Papadimitriou J.C., Rabsztyn A., Drachenberg C., Tildon J.T. Gastrointestinal abnormalities in children with autistic disorder. J Pediatrics. 135:(5):1999;559-563.
21. Furlano R.I., Anthony A., Day R., Brown A., McGarvey L., Thomson M.A., et al. Colonic CD8 and gamma delta T-cell infiltration with epithelial damage in children with autism. J Pediatr. 138:(3):2001;366-372.
22. Waring R.H., Klovrza L.V. Sulphur metabolism in autism. J Nutr Environ Med. 10:2000;25-32.
23. Bottini N., DeLuca D., Saccucci P., Fiumara A., Elia M., Porfirio M.C., et al. Autism: evidence of association with adenosine deaminase genetic polymorphism. Neurogenetics. 3:(2):2001;111-113.
24. Kern J.K., Miller V.S., Cauller P.L., Kendall P.R., Mehta P.J., Dodd M. Effectiveness of N,N-Dimethylglycine in autism/PDD. J Child Neurol. 16:(3):2001;169-173.
25. Kern J.K., Miller V.S., Evans P.A., Trivedi M.H. Efficacy of porcine secretin in children with autism and pervasive developmental disorders. J Autism Dev Disord. 32:(3):2002;153-160.
26. Bauman M.L., Filipek P.A., Kemper T.L. Early infantile autism. Schmahmann J.D. The Cerebellum and Cognition. 1997;367-386 Academic Press, New York.
27. Davidovitch M., Glick L., Holtzman G., Tirosh E., Safir M.P. Developmental regression in autism: maternal perception. J Autism Dev Disord. 30:(2):2000;113-119.
28. Tuchman R. Pervasive developmental disorder: neurologic perspective. Acta Neuropediatrica. 2:1996;82-93.
29. Rice D., Barone S. Jr. Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ Health Perspect. 108:(Suppl 3):2000;511-533.
30. Courchesne E., Yeung-Courchesne R., Press G.A., Hesselink J.R., Jernigan T.L. Hypoplasia of cerebellar vermal lobules VI and VII in autism. N Engl J Med. 318:1988;1349-1354.
31. Murakami J.W., Courchesne E., Press G.A., Yeung-Courchesne R., Hesselink J.R. Reduced cerebellar hemisphere size and its relationship to vermal hypoplasia in autism. Arch Neurol. 46:1989;689-694.
32. Heh C.W., Smith R., Wu J., Hazlett E., Russell A., Asarnow R., et al. Positron emission tomography of the cerebellum in autism. Am J Psychiatry. 146:(2):1989;242-245.
33. Courchesne E., Press G.A., Yeung-Courchesne R. Parietal lobe abnormalities detected with MR in patients with infantile autism. Am J Roentgenol. 160:(2):1993;387-393.
34. Welsh J.P., Yuen G., Placantonakis D.G., Vu T.Q., Haiss F., O'Hearn E., et al. Why do Purkinje cells die so easily after global brain ischemia? Aldolase C, EAAT4 and the cerebellar contribution to post-hypoxic myoclonus. Adv Neurol. 89:2002;331-359.
35. Fonnum F., Lock E.A. Cerebellum as a target for toxic substances. Toxicol Lett. 112-113:2000;9-16.
36. Cervos-Navarro J., Diemer N.H. Selective vulnerability in brain hypoxia. Crit Rev Neurobiol. 6:(3):1991;149-182.
37. Butterworth R.F. Pathophysiology of cerebellar dysfunction in the Wernicke-Korsakoff syndrome. Can J Neurol, Sci. 20:(3):1993;123-126.
38. O'Hearn E., Molliver M.E. The olivocerebellar projection mediates ibogaine-induced degeneration of Purkinje cells: a model of direct, trans-synaptic excitotoxicity. J Neurosci. 17:(22):1997;8828-8841.
39. Brorson J.R., Manzolillo P.A., Gibbons S.J., Miller R.J. AMPA receptor desensitization predicts the selective vulnerability of cerebellar Purkinje cells to excitotoxicity. J Neurosci. 15:(6):1995;4515-4524.
40. Kang T.C., Park S.K., Hwang I.K., An S.J., Bahn J.H., Choi S.Y., et al. The decreases in calcium binding proteins and neurofilament immunoreactivities in the Purkinje cell of the seizure sensitive gerbils. Neurochem Int. 40:(2):2002;115-122.
41. Brorson J.R., Manzolillo P.A., Gibbons S.J., Miller R.J. AMPA receptor desensitization predicts the selective vulnerability of cerebellar Purkinje cells to excitotoxicity. J Neurosci. 15:1995;4515-4524.
42. Reader T.A., Senecal J. Topology of ionotropic glutamate receptors in brains of heterozygous and homozygous weaver mutant mice. Synapse. 42:(4):2001;213-233.
43. Kish S.J., Young T., Li P.P., Siu K.P., Robitaille Y., Ball M.J., et al. Elevated stimulatory and reduced inhibitory G protein alpha subunits in cerebellar cortex of patients with dominantly inherited olivopontocerebellar atrophy. J Neurochem. 60:(5):1993;1816-1820.
44. Reade T.A., Senecal J. Distribution of glutamate receptors of the NMDA subtype in brains of heterozygous and homozygous weaver mutant mice. Neurochem Res. 26:(6):2001;579-589.
45. Hornig M., Solbrig M., Horscroft N., Weissenbock H., Lipkin W.I. Borna disease virus infection of adult and neonatal rats: models for neuropsychiatric disease. Curr Top Microbiol Immunol. 253:2001;157-177.
46. Kenntner N., Tataruch F., Krone O. Heavy metals in soft tissue of white-tailed eagles found dead or moribund in Germany and Austria from 1993-2000. Envirol Toxicol Chem. 20:(8):2001;1831-1837.
47. Hua J., Brun A., Berlin M. Pathological changes in the Brown Norway rat cerebellum after mercury vapor exposure. Toxicology. 104:(1-3):1995;83-90.
48. Ross J.F., Switzer R.C., Poston M.R., Lawhorn G.T. Distribution of bismuth in the brain after intraperitoneal dosing of bismuth subnitrate in mice: implications for routes of entry of xenobiotic metals into the brain. Brain Res. 725:(2):1996;137-154.
49. Sorensen F.W., Larsen J.O., Eide R., Schionning J.D. Neuron loss in cerebellar cortex of rats exposed to mercury vapor: a stereological study. Acta Neuropathol. 100:(1):2000;95-100.
50. McDonald J.W., Shapiro S.M., Silverstein F.S., Johnston M.V. Role of glutamate receptor-mediated excitotoxicity in bilirubin-induced brain injury in the Gunn rat model. Exp Neurol. 150:(1):1998;21-29.
51. Saavedra H., DeMarinis A., Palestini M. Neuronal changes induced by chronic toluene exposure in the cat. Arch Ital Biol. 134:1996;217-225.
52. Bhatia K.P., Brown P., Gregory R., Lennox G.G., Manji H., Thompson P.D., et al. Progressive myoclonic ataxia associated with coeliac disease: the myoclonus is of cortical origin, but the pathology is in the cerebellum. Brain. 118 (pt5):1995;1087-1093.
53. Tijssen M.A., Thom M., Ellison D.W., Wilkins P., Barnes D., Thompson P.D., et al. Cortical myoclonus and cerebellar pathology. Neurology. 54:(6):2000;1350-1356.
54. Hadjivassiliou M., Boscolo S., Davies-Jones G.A., Grunewald R.A., Not T., Sanders D.S., et al. The humoral response in the pathogenesis of gluten ataxia. Neurology. 58:(8):2002;1221-1226.
55. Ghez C. The cerebellum. Kandel E., Schwartz J., Jessell T. Principles of Neural Science. 3rd Edition:1991;626-646 Appleton and Lange, Norwalk.
56. Sugimori M., Llinas R.R. Real-time imaging of calcium influx in mammalian cerebellar Purkinje cells in vitro. Proc Natl Acad Sci USA. 87:1990;5084-5088.
57. Kreitzer A.C., Gee K.R., Archer E.A., Regehr W.G. Monitoring presynaptic calcium dynamics in projection fibers by in vivo loading of a novel calcium indicator. Neuron. 27:2000;25-32.
58. O'Hearn E., Molliver M.E. The olivocerebellar projection mediates ibogaine-induced degeneration of Purkinje cells: a model of indirect, trans-synaptic excitotoxicity. J Neurosci. 17:1997;8828-8841.
59. Altman J., Bayer S.A. The Cerebellar System. 1997;CRC Press, New York.
60. Martin C., Chapman K.E., Seckl J.R., Ashley R.H. Partial cloning and differential expression of ryanodine receptor/calcium-release channel genes in human tissues including the hippocampus and the cerebellum. Neuroscience. 85:(1):1998;205-216.
61. Vajda F.J. Neuroprotection and neurodegenerative disease. J Clin Neurosci. 9:(1):2002;4-8.
62. Ahlsen G., Rosengren L., Belfrage M., Palm A., Haglid K., Hamberger A., et al. Glial fibrillary acidic protein in the cerebrospinal fluid of children with autism and other neuropsychiatric disorders. Biol Psychiatry. 33:(10):1993;734-743.
63. Bauman M.L., Kemper T.L. Neuroanatomic observations of the brain in autism. Bauman M.L., Kemper T.L. The Neurobiology of Autism. 1994;119-145 Johns Hopkins University Press, Baltimore.
64. Taylor D.C., Neville B.G., Cross J.H. Autistic spectrum disorders in childhood epilepsy surgery candidates. Eur Child Adolesc Psychiatry. 8:(3):1999;189-192.
65. Wakefield A.J., Anthony A., Murch S.H., Thomson M., Montgomery S.M., Davies S., et al. Enterocolitis in children with developmental disorders. Am J Gastroenterol. 95:(9):2000;2285-2295.
66. Edelson S.B., Cantor D.S. Autism: xenobiotic influences. Toxicol Ind Health. 14:(4):1998;553-563.
67. Ashley D.L., Bonin M.A., Cardinali F.L., McCraw J.M., Wooten J.V. Blood concentrations of volatile organic compounds in a nonoccupationally exposed US population and in groups with suspected exposure. Clin Chem, ;40(7 Pt. 2:1994;1401-1404.
68. Shehata A.R. A multi-route exposure assessment of chemically contaminated drinking water. Toxicol Ind Health. 1:(4):1985;277-298.
69. Srivastava P.K., Pandit G.G., Sharma S., Mohan-Rao A.M. Volatile organic compounds in indoor environments in Mumbai. India, Sci Total Environ. 255:(1-3):2000;161-168.
70. Wallace L.A., Pellizzari E.D., Hartwell T.D., Davis V., Michael L.C., Whitmore R.W. The influence of personal activities on exposure to volatile organic compounds. Environ Res. 50:(1):1989;37-55.
71. Kallen R.J. A long letter and an even longer reply about autism magnetoencephalography and electroencephalography. Pediatrics. 107:(5):2001;1232-1235.
72. Glascoe F.P. It's not what it seems: the relationship between parents' concerns and children with global delays. Clin Pediatr. 33:1994;292-296.
73. Glascoe F.P., Sandler H. Value of parents' estimates of children's developmental ages. J Pediatr. 127:1995;831-835.
74. Glascoe F.P. Parents' concerns about children's development: prescreening technique or screening test? Pediatrics. 99:1997;522-528.
75. Glascoe F.P., Dworkin P.H. The role of parents in the detection of developmental and behavioral problems. Pediatrics. 95:1995;829-836.
76. Schmahmann J.D., Padya D.N. The cerebellar system. Schmahmann J.D. The Cerebellum and Cognition. 1997;31-60 Academic Press, New York.
77. Kern J.K. The possible role of the cerebellum in autism/PDD; dysruption of a multisensory feedback loop. Med Hypotheses. 59:(3):2002;255-260.
78. Crispino L., Bullock T.H. Cerebellum mediates modality-specific modulation of sensory responses of midbrain and forebrain in rat. Proc Natl Acad Sci USA. 81:1984;2917-2920.
79. Chambers W.W. Electrical stimulation of the interior of the cerebellum in the cat. Am J Anat. 80:1947;55-94.
80. Baranek G.T., Foster L.G., Berkson H. Tactile defensiveness and stereotyped behaviors. Am J Occup Ther. 51:(2):1997;91-95.
81. Heath R., Dempsey C.W., Fontana C.J., Fitzjarrell A.T. Feedback loop between cerebellum and septal-hippocampal sites; its role in emotion and epilepsy. Biol Psychiatry. 673:(1):1996;141-148.
82. Fiez J.A., Raife E.A., Balota D.A., Schwarz J.P., Raichle M.E., Petersen S.E. A positron emission tomography study of the short-term maintenance of verbal information. J Neurosci. 16:1996;808-822.
83. Fiez J.A., Raichle M.E. Linguistic processing. Schmahmann J.D. The cerebellum and cognition. 1997;233-254 Academic Press, New York.
84. Kent R.D., Netsell R., Abbs J.H. Acoustic characteristics of dysarthria associated with cerebellar disease. J Speech Hearing Res. 22:1979;627-648.
85. Schmahmann J.D., Padya D.N. Prefrontal cortex projections to the basilar pons in rhesus monkey: implications for the cerebellar contribution to higher function. J Comp Neurol. 289:1995;53-73.
86. Gaze R.M., Keating M.J., Szekely G., Beazley L. Binocular interaction in the formation of specific intertectal neuronal connexions. Proc R Soc London, Biol. 175:1970;107-147.
87. Schopler E., Reichler R.J., Renner B.R. The Childhood Autism Rating Scale. Western Psychological Services. 12031:1994;900251251.
88. Ghez C. The cerebellum. Kandel E., Schwartz J., Jessell T. Principles of Neural Science. 3rd Edition:1991;626-646 Appleton and Lange, Norwalk.
89. Thompson R.F., Bao S., Chen L., Cipriano B.D., Grethe J.S., Kim J.J., et al. Associative learning. Schmahmann J.D., et al. The cerebellum and cognition. 1997;151-189 Academic Press, New York.